glp 1 and pulmonary embolism A recent study suggests that GLP-1 medications, commonly prescribed for managing diabetes obesity, may also lower the risk of dangerous blood clots., The study’s lead author, Dr. Rushad Patell of Glucagon-like peptide-1 receptor agonists are

Is the introduction mean that because were circumventing that part of the ecosystem that the body relaxes or and this is an interesting or are the receptor sites in the gut, the ones that are actually now being activated and those historically havent been activated

"What other disease state would they require the medication to be prescribed by a provider through one organization?" Ella Adams is a reporter for the State House News Service and State Affairs Massachusetts

Accessed March 30, 2026.

Ye Y, Perez-Polo JR, Aguilar D, Birnbaum Y: The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury

Ther Adv Musculoskelet Dis

Vargas EJ, Rizk M, Gomez-Villa J, Edwards PK, Jaruvongvanich V, Storm AC, et al